跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA TINTED BB CREAM SPF50+ - TGA Drug Approval Details
Approvals
/
TGA
/
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA TINTED BB CREAM SPF50+
Approved
STANDARD
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA TINTED BB CREAM SPF50+
L'Oreal Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ecb17eb22e4398cc
Company
L'Oreal Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ecb17eb22e4398cc
Product Name
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA TINTED BB CREAM SPF50+
Artg Id
307005
Artg Name
LA ROCHE POSAY LABORATOIRE DERMATOLOGIQUE ANTHELIOS ULTRA TINTED BB CREAM SPF50+
Sponsor
L'Oreal Australia Pty Ltd
Company Detail Path
/organization/loreal-australia-pty-ltd
Artg Date
2018-07-13
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
LI
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ecb17eb22e4398cc
Type
Standard
Back to TGA Approvals
